United States Orphan Drug Designation for Treatment of Soft Tissue Sarcomas Granted to SPEAR T-cells Targeting MAGE-A4

September 9, 2019

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search